S
Standard Biotools
Biotech tools company that creates microfluidic-based chips and instrumentation for biological research
At a glance
- Founded
- 1999
- Headquarters
- Boston, United States
- Listing
- IPO 2011
- Sector
- Biotech & Life Sciences
- Power Law
- Thoroughbred$100M+ revenue
Latest news
Press, funding announcements and product moves mentioning Standard Biotools.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series B and later17 investors entered at this stage
- GEGE Equity
- SFSmallcap World Fund
- AVAlloy Ventures
- EDEDBI
InterWest Partners
Versant Ventures- LBLehman Brothers
- FCFidelity Contrafund
- WAWasatch Advisors
- CACaltech
- CTCalifornia Institute of Technology
- INInvus
- BCBio*One Capital
- CCCross Creek
- LVLilly Ventures
- EPEuclidSR Partners
- CACross Creek Advisors
Source: Dealroom Talent Intelligence.
Alumni founders
Former Standard Biotools employees who went on to found companies, sorted by Dealroom signal score.
ITIntellia TherapeuticsEst. 2014
John CorlissUnited States
IOIonpathEst. 2014
Harris FienbergUnited States
PRProviviEst. 2013
Frances ArnoldUnited States
MBMantra BioEst. 2016Global footprint
team presence
across markets
Patents
62 active patent families included in this estimate.
A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.
Market sentiment
An AI-synthesised read of the highest-engagement posts about Standard Biotools on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Standard Biotools on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.